![](https://investorshub.advfn.com/uicon/316655.png?cb=1525205918)
Friday, March 05, 2021 11:32:44 AM
On March 3, 2021, the Board of Directors of AngioSoma, Inc. (the “Company”) appointed James C. Katzaroff Director, President and Chief Executive Officer of the corporation.
On March 3, 2021, the Board of Directors of the Company accepted Alex K. Blankenship’s resignation from all positions with the Company. Ms. Blankenship also transferred voting control to James C. Katzaroff.
James C. Katzaroff successfully negotiated with the holder of a patented treatment for Multiple Sclerosis for an exclusive perpetual license. Mr. Katzaroff is the founder of Advanced Medical Isotope Corp. (now known as Radiogel) and was the Chairman and Chief Executive Officer from 2007 through December 2016. Since December 2016 to present, Mr. Katzaroff is Senior Managing Director at KATMO, LLC.
Hummmm they are located in Huston !!! This could be HUGE !!! IMO !!!
Weeeeeeee !!! $$ PVDG $$
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM